Use of direct oral anticoagulants for the prevention and treatment of thromboembolic disease in patients with reduced renal function: a short review of the clinical evidence
Kristine C Willett, Amanda M Morrill Department of Pharmacy Practice, School of Pharmacy, MCPHS University, Manchester, NH, USA Background: The use of direct oral anticoagulants (DOACs) is restricted by the limitations of clinical trials guiding therapy for patients with renal impairment, as many...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2017-04-01
|
| Series: | Therapeutics and Clinical Risk Management |
| Subjects: | |
| Online Access: | https://www.dovepress.com/use-of-direct-oral-anticoagulants-for-the-prevention-and-treatment-of--peer-reviewed-article-TCRM |